A clinical trial investigating the safety and tolerability of a novel formulation of 5-MeO-DMT in psychedelic-naive subjects has dosed its first cohort of volunteers.
The successful completion of Phase I of the world’s first clinical trial investigating the use of DMT-assisted therapy could lay the foundation for a “new paradigm”...
Novel analogues of the psychedelic compound 5-MeO-DMT have shown demonstrable safety in preclinical results.
PharmaDrug Inc.